Validation of biomarkers to predict response to immunotherapy in cancer: Volume II — clinical validation and regulatory considerations

There is growing recognition that immunotherapy is likely to significantly improve health outcomes for cancer patients in the coming years. Currently, while a subset of patients experience substantial clinical benefit in response to different immunotherapeutic approaches, the majority of patients do...

Descripción completa

Detalles Bibliográficos
Autores principales: Dobbin, Kevin K., Cesano, Alessandra, Alvarez, John, Hawtin, Rachael, Janetzki, Sylvia, Kirsch, Ilan, Masucci, Giuseppe V., Robbins, Paul B., Selvan, Senthamil R., Streicher, Howard Z., Zhang, Jenny, Butterfield, Lisa H., Thurin, Magdalena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5109653/
https://www.ncbi.nlm.nih.gov/pubmed/27891226
http://dx.doi.org/10.1186/s40425-016-0179-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5109653/
https://www.ncbi.nlm.nih.gov/pubmed/27891226
http://dx.doi.org/10.1186/s40425-016-0179-0

Ejemplares similares